Prognostic impact of p53 and/or NY-ESO-1 autoantibody induction in patients with gastroenterological cancers.
Isamu HoshinoYoshihiro NabeyaNobuhiro TakiguchiHisashi GunjiFumitaka IshigeYosuke IwatateFumiaki ShiratoriSatoshi YajimaRei OkadaHideaki ShimadaPublished in: Annals of gastroenterological surgery (2020)
The presence of s-p53-Abs and/or s-NY-ESO-1-Abs was associated with tumor progression in ESCC and gastric cancer. These autoantibodies might have poor prognostic impacts on gastric cancer (UMIN000014530).